Medical Research
(H12)
990 on File
CANCER ACTIVE INC
Financial strength (30%)
19/100
Reliability (20%)
45/100
Effectiveness (25%)
31/100
Impact (25%)
No data yet
CharityAI™ Score
Not yet evaluated
Financial Overview — FY 2023
$97K
Total Revenue
$128K
Total Expenses
$-60,665
Net Assets
N/A
Employees
Revenue Sources
Expense Breakdown
Program Expense Ratio
17.3%
Fundraising Efficiency
N/A
Operating Reserve
-5.70x
Liability-to-Asset
1020.0%
Revenue Diversification
93.8%
Compared with Peers
FY 2023
Compared with 1,004 similar organizations
(United States, Medical Research, $100K–$1M in expenses), FY 2023.
This organization
Middle half of peers (P25–P75)
Peer median
| Ratio | This org | Peer median | Position (P10 → P90) | |
|---|---|---|---|---|
|
Program expense ratio
Program expenses / total expenses
· higher is better
|
17.3% | 86.3% |
P10P90
|
Bottom quarter |
|
Operating reserve
Months of expenses covered by net assets
· higher is better
|
-5.7 mo | 13.1 mo |
P10P90
|
Bottom quarter |
|
Liabilities to assets
Total liabilities / total assets
· lower is better
|
1020.0% | 0.3% |
P10P90
|
Bottom quarter |
|
Revenue concentration
Share of revenue from the largest source
· lower is better
|
93.8% | 95.3% |
P10P90
|
Above median |
|
Revenue growth
Year over year revenue growth
|
-46.7% | 4.8% |
P10P90
|
|
|
Expense growth
Year over year expense growth
|
-28.5% | 12.9% |
P10P90
|
|
|
Surplus margin
Surplus as a share of revenue
|
-32.1% | -0.2% |
P10P90
|
Financial History
| Year | Revenue | Expenses | Net Assets | Program % | Staff |
|---|---|---|---|---|---|
| 2023 | $97K | $128K | $-60,665 | 17.3% | — |
| 2022 | $181K | $179K | $-29,612 | 81.6% | — |
| 2021 | $59K | $41K | N/A | — | 1 |
Donor Reviews
Write a ReviewNo reviews yet
Be the first to share your experience with this organization.